Ignite Creation Date:
2024-05-05 @ 9:50 PM
Last Modification Date:
2024-10-26 @ 10:10 AM
Study NCT ID:
NCT00977431
Status:
COMPLETED
Last Update Posted:
2019-02-18
First Post:
2009-09-14
Brief Title:
Open Label Trial to Explore Safety of Combining Afatinib BIBW 2992 and Radiotherapy With or Without Temozolomide in Newly Diagnosed Glioblastoma Multiform
Sponsor:
Boehringer Ingelheim
Organization:
Boehringer Ingelheim
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-09-17
Start Date Type:
ACTUAL
Primary Completion Date:
2017-09-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-09-12
Completion Date Type:
ACTUAL
First Submit Date:
2009-09-14
First Submit QC Date:
September 14 2009
Study First Post Date:
2009-09-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2019-02-18
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-02-11
Last Update Post Date:
2019-02-18
Last Update Post Date Type:
ACTUAL